PNPLA3 and hepatocellular carcinoma: The PNPLA3 GG genotype seems to have an approximately twofold higher risk of developing hepatic steatosis, a three- to four-fold higher risk of developing NASH and cirrhosis, and an up to 12-fold higher risk of developing HCC as compared with the PNPL3 CC genotype [63].